NDC 63868-949

Feminine Anti-Itch Creme

Benzocaine, Resorcinol

Feminine Anti-Itch Creme is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Quality Choice (chain Drug Marketing Association). The primary component is Benzocaine; Resorcinol.

Product ID63868-949_aa6cc288-ad13-92e2-e053-2995a90a9e16
NDC63868-949
Product TypeHuman Otc Drug
Proprietary NameFeminine Anti-Itch Creme
Generic NameBenzocaine, Resorcinol
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2020-02-01
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart348
Labeler NameQuality Choice (CHAIN DRUG MARKETING ASSOCIATION)
Substance NameBENZOCAINE; RESORCINOL
Active Ingredient Strength6 g/28g; g/28g
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 63868-949-01

28 g in 1 TUBE (63868-949-01)
Marketing Start Date2020-02-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Feminine Anti-Itch Creme" or generic name "Benzocaine, Resorcinol"

NDCBrand NameGeneric Name
63868-949Feminine Anti-Itch CremeBENZOCAINE, RESORCINOL
0363-0673Anti ItchBenzocaine, Resorcinol
0113-7142basic care vagicaineBenzocaine, Resorcinol
55621-014Family WellnessBENZOCAINE, RESORCINOL
55621-016Family WellnessBENZOCAINE, RESORCINOL
46122-576good neighbor pharmacy vagicaineBenzocaine, Resorcinol
0113-0142good sense vagicaineBenzocaine, Resorcinol
49738-269Image Essentials VagicaineBenzocaine, Resorcinol
55758-300OptimV Anti-ItchBenzocaine, Resorcinol
21130-142signature care vagicaineBenzocaine, Resorcinol
49738-142smart sense vagicaineBenzocaine, Resorcinol
36800-142topcare vagicaineBenzocaine, Resorcinol
11673-142Up and up vagicaineBenzocaine, Resorcinol
76466-010VAGI-CURE (MAXIMUM STRENGTH)BENZOCAINE, RESORCINOL
29500-7820VagicaineBENZOCAINE, RESORCINOL
41250-142VagicaineBenzocaine, Resorcinol
59779-588Vagicaine Maximum Strength Anti-Itch CreamBenzocaine, Resorcinol

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.